News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$ANAB | #Anaptysbio Spikes After Drug Designation
Nice spike in the afterhours session, lets hope we
can get some continuation tomorrow.
Target $29.00 to Fib Golden Pocket
Also a very large gap to fill at $35.00
AnaptysBio gets orphan drug designation of imsidolimab for pustular psoriasis
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$10 to da moon 
|
Followers
|
2
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
18
|
|
Created
|
10/13/17
|
Type
|
Free
|
| Moderators | |||
| Reporting Status | U.S. Reporting: SEC Reporting |
| Latest Report | Jun 30, 2017 10-Q |
| CIK | 0001370053 |
| Fiscal Year End | Not Available |
| OTC Marketplace | Not Available |
| SIC - Industry Classification | Not Available |
| Incorporated In: | DE, USA |
| Year of Inc. | Not Available |
| Employees | Not Available |
| Market Value1 | $1,440,247,867 | a/o Oct 12, 2017 | |
| Authorized Shares | Not Available | ||
| Outstanding Shares | 20,342,484 | a/o Aug 08, 2017 | |
| -Restricted | Not Available | ||
| -Unrestricted | Not Available | ||
| Held at DTC | Not Available | ||
| Float | Not Available | ||
| Par Value | Not Available |
| Shareholders of Record | 84 | a/o Mar 08, 2017 |
| Ex. Date | Record Date | Pay Date | |
|---|---|---|---|
| Dividends are not adjusted for stock splits | |||
| |
| Short Interest | (%) |
| Significant Failures to Deliver | No |
1Market Value calculated only for respective security
